Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immune Related Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01792570
What this trial is testing

DRV/r + RPV QD: Efficacy and Toxicity Reduction

Who this might be right for
Human Immunodeficiency Virus
ASST Fatebenefratelli Sacco 37
Not applicableStudy completedNCT05753241
What this trial is testing

The Relationship Between Allergic Rhinitis and the Risk of Symptom in Patients With Mild COVID-19

Who this might be right for
COVID-19Allergic Rhinitis
qinxiu zhang 1,100
Not applicableStudy completedNCT00002354
What this trial is testing

Indinavir Sulfate Given Together With Stavudine to HIV-Positive Patients

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 540
Not applicableStudy completedNCT00096772
What this trial is testing

Collection of Blood Samples From HIV Infected People

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 2,502
Testing effectiveness (Phase 2)Study completedNCT00056875
What this trial is testing

Recombinant Human Keratinocyte Growth Factor in Unrelated and Related Transplants

Who this might be right for
Graft Versus Host Disease
University of Michigan 50
Early research (Phase 1)Study completedNCT04095273
What this trial is testing

Study to Test How Well Patients With Advanced Solid Tumors Respond to Treatment With the Elimusertib in Combination With Pembrolizumab, to Find the Optimal Dose for Patients, How the Drug is Tolerated and the Way the Body Absorbs, Distributes and Discharges the Drug

Who this might be right for
Advanced Solid Tumors
Bayer 56
Not applicableUnknownNCT03062072
What this trial is testing

Emergence of Chemotherapy Related Hyperglycemia in nOn-diabetic Patients

Who this might be right for
CancerColon CancerBreast Cancer+1 more
National Cancer Center, Korea 300
Early research (Phase 1)Looking for participantsNCT07237594
What this trial is testing

IL-17 Blockade to Decrease irAEs (REPLAY)

Who this might be right for
Metastatic Melanoma
Duke University 4
Testing effectiveness (Phase 2)Study completedNCT00002151
What this trial is testing

A Randomized, Double-Blind Active-Controlled, Dose-Ranging Study of the Safety and Efficacy of Chronically Administered MDL 28,574A in the Treatment of HIV-Infected Patients

Who this might be right for
HIV Infections
Hoechst Marion Roussel 200
Not applicableStudy completedNCT00002075
What this trial is testing

Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis

Who this might be right for
Meningitis, CryptococcalHIV Infections
Pfizer
Testing effectiveness (Phase 2)Study completedNCT00002265
What this trial is testing

An Open-Label, Multicenter Study to Evaluate the Safety and Tolerability of Dideoxycytidine (ddC) in Patients With AIDS or Advanced ARC Who Previously Demonstrated Intolerance to Zidovudine (AZT) in Protocol N3300 or N3492

Who this might be right for
HIV Infections
Hoffmann-La Roche
Not applicableLooking for participantsNCT06613165
What this trial is testing

Exploring the Treatment Duration of PD-1 Neoadjuvant Therapy in Stage II-III dMMR Rectal Cancer

Who this might be right for
Immune-related Adverse EventNeoadjuvant TherapydMMR Colorectal Cancer
Xijing Hospital 100
Testing effectiveness (Phase 2)Study completedNCT00054353
What this trial is testing

Reduced-Intensity Conditioning Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Multiple Myeloma

Who this might be right for
Refractory Multiple Myeloma
Fred Hutchinson Cancer Center 16
Not applicableStudy completedNCT04817553
What this trial is testing

Impact of COVID-19 on the Clinical Outcomes and Management of IgG4 Related Disease Patients

Who this might be right for
IgG4 Related DiseaseCovid19
Chinese University of Hong Kong 124
Not applicableStudy completedNCT00577798
What this trial is testing

Cardiac Magnetic Resonance Imaging in Patients With Non-Hodgkin Lymphoma or Hodgkin Lymphoma Receiving Doxorubicin

Who this might be right for
Cardiac ToxicityChemotherapeutic Agent ToxicityLymphoma
University of Nebraska 10
Testing effectiveness (Phase 2)UnknownNCT05246293
What this trial is testing

Tofacitinib in the Treatment of Rheumatoid Arthritis-related Interstitial Lung Disease.

Who this might be right for
Rheumatoid ArthritisInterstitial Lung Disease
National Institute of Respiratory Diseases, Mexico 60
Not applicableLooking for participantsNCT06501781
What this trial is testing

Peer Behavioral Activation Utilization to Improve Substance Use and HIV Outcomes in People Receiving Long Acting Injectable-PrEP/ART (PUSH)

Who this might be right for
HIV InfectionsSubstance Use
University of Maryland, Baltimore 186
Not applicableUnknownNCT05299112
What this trial is testing

An Exploratory Study of Increased Preterm Arginine INTake (PAINT18)

Who this might be right for
PretermNutritional DeficiencyImmune System and Related Disorders
Liverpool Women's NHS Foundation Trust 24
Not applicableLooking for participantsNCT06810739
What this trial is testing

The Women's Screening and Self-Testing Program (PROMETA) Study

Who this might be right for
Human Papilloma Virus Related Cervical Carcinoma
Tulane University 8,445
Not applicableStudy completedNCT00000900
What this trial is testing

The Effects of Illnesses on HIV Levels in the Body

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 26
Next Page